Literature DB >> 1441700

[Effectiveness of propafenone in congenital ectopic junctional tachycardia--a case report].

T Paul1, A Reimer, H C Kallfelz.   

Abstract

Junctional ectopic tachycardia is associated with a poor prognosis when it occurs in newborns and young infants. Like other automatic tachyarrhythmias, junctional ectopic tachycardia has been shown to be very resistant to medical treatment. Successful therapy with propafenone in a newborn with congenital junctional ectopic tachycardia is presented. Due to its high effectiveness, safety, and lack of side-effects, propafenone appears to be a valuable drug in the treatment of young patients with congenital junctional ectopic tachycardia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1441700

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  1 in total

Review 1.  New antiarrhythmic drugs in pediatric use: propafenone.

Authors:  T Paul; J Janousek
Journal:  Pediatr Cardiol       Date:  1994 Jul-Aug       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.